Scientific article
Open access

NANO-SBT-PEDF delivery system: A promising approach against ovarian cancer?

Published inHeliyon, vol. 9, no. 2, e13676
Publication date2023-02

Pigment epithelium-derived factor (PEDF) is a secreted glycoprotein involved in various bio- logical processes. Its expression declines during ovarian carcinogenesis where it could decrease macrophages polarization, inhibit angiogenesis and induce apoptosis. Altogether, PEDF repre- sents an ideal anti-cancer agent against ovarian cancer. We previously proposed the non-viral Sleeping Beauty transposon (SBT) system to stably integrate the PEDF transgene into ovarian cancer cells. Here, we report the development of liposomes and lipid nanoparticles for SBT-PEDF gene therapy. We determined that the SBT-PEDF nanolipid delivery system was the best system to increase the expression of PEDF in ovarian cancer spheroids. We also developed an ex vivo model of ovarian tumors which allowed us to show that nanolipoplexe in combination to paclitaxel exhibits synergistic and effective anti-tumor efficacy on ovarian tumors. These findings demon- strate that lipid nanoparticle for SBT-PEDF gene therapy may be a promising therapeutic approach for ovarian cancer.

  • Ex vivo ovarian tumor model
  • Lipid nanoparticle
  • Liposome
  • PEDF
  • Sleeping beauty transposon
Citation (ISO format)
RIBAUX, Pascale Garlonne et al. NANO-SBT-PEDF delivery system: A promising approach against ovarian cancer? In: Heliyon, 2023, vol. 9, n° 2, p. e13676. doi: 10.1016/j.heliyon.2023.e13676
Main files (1)
Article (Published version)
ISSN of the journal2405-8440

Technical informations

Creation07/19/2023 2:50:16 PM
First validation01/05/2024 12:11:59 PM
Update time01/05/2024 12:11:59 PM
Status update01/05/2024 12:11:59 PM
Last indexation01/18/2024 1:58:50 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack